Letter

Prophylactic heparin in palliative care: A cautious welcome…

BMJ 2006; 332 doi: 10.1136/bmj.332.7543.728-b (Published 23 March 2006)
Cite this as: BMJ 2006;332:728.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Victor Pace, consultant in palliative medicine (v.pace@stchristophers.org.uk),
  2. Emma Hal, consultant in palliative medicine,
  3. Catherine Bailey, specialist registrar
  1. St Christopher's Hospice, London SE26 6DZ

    EDITOR—Although we agree with the conclusions of the survey reported by Noble et al of patients' views on receiving low molecular weight heparin in palliative care, we wish to sound some notes of caution.1 Reasons other than preciousness about patients' comfort lie behind a reluctance to give many patients in palliative care prophylactic treatment with low molecular weight heparin.

    In advanced cancer …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular